Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Minority Interest (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Minority Interest readings, the most recent being -$254000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Minority Interest changed 0.0% year-over-year to -$254000.0, compared with a TTM value of -$254000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of -$254000.0, changed 0.0% over the prior year.
  • Minority Interest hit -$254000.0 in Q4 2025 for Lisata Therapeutics, roughly flat from -$254000.0 in the prior quarter.
  • The five-year high for Minority Interest was -$254000.0 in Q1 2023, with the low at -$254000.0 in Q1 2023.
  • Median Minority Interest over the past 3 years was -$254000.0 (2023), compared with a mean of -$254000.0.
  • The largest YoY upside for Minority Interest was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • Year by year, Minority Interest stood at -$254000.0 in 2023, then changed by 0.0% to -$254000.0 in 2024, then changed by 0.0% to -$254000.0 in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at -$254000.0, -$254000.0, and -$254000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.